EMBL Australia

EMBL Australia Council Chair Emeritus Professor Ian Smith, Scientific Head Professor James Whisstock and Chief Operating Officer Annette Wittmann joined more than 400 global research infrastructure (RI) experts at the 2024 International Conference on Research Infrastructures (ICRI) in Brisbane (Meanjin). 

Professor Eduardo Eyras, Associate Professor Robert Weatheritt and Professor Chen Davidovich have been awarded four Discovery Project grants, totalling more than $3 million.

Professor James Whisstock is stepping down after eight transformative years as Scientific Head of EMBL Australia. Prof. Whisstock is a structural biologist at Monash Biomedicine Discovery Institute and Deputy Dean…

EMBL Australia group leader Dr William Roman has been awarded a 2024 Metcalf Prize for Stem Cell Research for his work growing human muscles on a chip. This technology will advance disease modelling, drug screening, cellular agriculture & biorobotics.

EMBL Australia is proud to be working together with Bioplatforms Australia, National Imaging Facility, Phenomics Australia, Population Health Research Network and Therapeutic Innovation Australia to keep Australians healthy through research innovation.

EMBL Australia Scientific Head Professor James Whisstock was one of the 31 newly elected Fellows of the Australian Academy of Health and Medical Sciences (AAHMS) for 2024 for his outstanding contributions to immunology.

EMBL Australia group leader Dr Qi Zhang has been awarded a prestigious fellowship to advance her epigenetics research, with the aim of generating fundamental knowledge to enable new cancer drugs.

Artificial intelligence (AI) and its transformative role in life sciences took centre stage at an event featuring EMBL-EBI Director Prof Ewan Birney and jointly hosted by EMBL Australia and Bioplatforms Australia.

Pioneering biotech company Myostellar, led by EMBL Australia leadership team members Professor Peter Currie and Associate Professor Mikaël Martino, has received a $500,000 top-up from CUREator to continue developing new therapies for debilitating muscular dystrophies.

EMBL Australia Group Leader Professor Chen Davidovich has been awarded a $1.15m Australian Research Council (ARC) Future Fellowship to uncover how RNA helps control gene packaging and develop new methods to modify and introduce genes for advancements in biotechnology.